Share:
Notifications
Clear all

One of the most costliest Drug in Oncology, not only in India, but for USA as well - 50 mg vials are withdrawn by Merck - What are the implications?

0 Posts
1 Users
0 Reactions
703 Views
0
Topic starter

Very nice and useful interpretation and Implications discussed by one of the senior medical Oncologist - as follows:

We need understand the reasons why dose was changed from 2 mg per kg to 200 mg fixed dose

Initially 50 mg vial was there but later it was withdrawn

For obvious reasons

Now if u have 2 mg per kg dose for 75 kg man, it comes 150 mg

With 50 mg and 100 mg vial , it was easy to give

Now that 50 mg vial is withdrawn, for 150 mg dose , one has to use 2 vials of 100 mg and that will lead to wastage of 50 mg

As drug is covered by insurance in America, hospital do not want to use the 50 mg remained from 100 mg vial ,for the other patient, as they have no profit from it

So 50 mg has to be thrown off .

Now to get rid of this problem ,merc got rid of 50 mg vial and 2 mg per kg dose schedule

They keep fixed dose of 200 mg 3 weekly so that 100 mg 2 vials can be used for all pts and more vials are sold per patient

Now another intresting point is , there is another schedule of 400 mg every 6 weeks

Half life of drug is 3 weeks

So 6 weeks schedule would be enough

And if that is made 4 mg per kg 6 weekly , which means 300 mg for 75 kg man , one cycle will need 3 vials of 100 mg and hence inspite of having only 100 mg vial , one vial less will be needed per cycle and that wil save lots of money.

Also this will negate need of 50 mg vial .

The pharmacokinetic studies have already shown that 2 mg per kg is equal to 200 mg 3 weekly for receptors occupation

And 4 mg per kg is equal to 400 mg 6 weekly for receptor occupation

So the best solution for dosing problem without getting 50 mg vials, and subsequent drug wastage , is to have

4 mg per kg 6 weekly dose

Thats the best for pharmacy economics as well as pharmaco kinetics of pembro .

And for patients too .

 


Share: